Finance

Lists
PAM:NYSE
PAMPA ENERGIA SA
$79.81
-3.51%
(-2.90) 1D
$80.50
+0.87% (+0.69)
After hours
Closed: Aug 11, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PAM...
Open
$83.17
High
$84.30
Low
$79.17
Mkt. cap
4.59B
Avg. vol.
160.47K
Volume
224.06K
P/E ratio
13.12
52-wk high
$94.50
52-wk low
$54.95
EPS
$6.08
Beta
0.97
Shares outstanding
54.54M
No. of employees
2K
Open
$83.17
High
$84.30
Low
$79.17
Mkt. cap
4.59B
Avg. vol.
160.47K
Volume
224.06K
P/E ratio
13.12
52-wk high
$94.50
52-wk low
$54.95
EPS
$6.08
Beta
0.97
Shares outstanding
54.54M
No. of employees
2K
News stories
From web sources and news partners
Profile
Pampa Energía S.A. is the largest independent energy company in Argentina, with participation in the electricity and oil and gas value chain. It was founded in 2005 and is headquartered in Buenos Aires. Pampa is listed on the Buenos Aires Stock Exchange and is one of the Argentine companies with a greater weight on the Merval index. In addition, Pampa is one of the Argentine companies with a greater weight on the MSCI Argentina Index. Pampa has a Level II American Depositary Share program listed in the New York Stock Exchange, and all ADS represents 25 common shares. Wikipedia
About PAMPA ENERGIA SA
CEO-
Employees1.92K
Founded2005
Headquarters-
SectorPublic utility
Websiteri.pampa.com
Analyst ratings
Based on 2 analysts giving stock ratings to PAM in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PAM in the last 3 months.
Highest
Current $79.81
$160.00 (+100.48%)
Average
$130.75 (+63.83%)
Lowest
$101.50 (+27.18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Bank of America Securities
Buy
Reiterated
$160.00
+100.5%
07/30/2026
Rodolfo Angele
J.P. Morgan
Hold
Maintained
$101.50
+27.2%
06/01/2026
Lilyanna Yang
HSBC
Buy
Upgraded
$97.00
+21.5%
03/12/2026
Gustavo Faria
Bank of America Securities
Buy
Maintained
-
-
11/17/2025
Andres Cardona
Citi
Buy
Upgraded
$113.00
+41.6%
10/31/2025
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (ARS)
ARS 194.64 / ARS 145.62
+33.66%beat
Revenue / Est. (ARS)
1.12T / 1.14T
-1.80%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in ARS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
591.00M
507.00M
573.00M
746.00M
Cost of goods sold
375.00M
370.36M
382.00M
482.00M
Cost of revenue
375.00M
370.36M
382.00M
482.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.00M
90.00M
69.00M
77.00M
Operating expense
66.00M
114.00M
80.00M
73.00M
Total operating expenses
441.00M
484.36M
462.00M
555.00M
Operating income
150.00M
22.64M
111.00M
191.00M
Other non operating income
15.00M
92.00M
8.00M
15.00M
EBT including unusual items
138.00M
152.00M
150.00M
241.00M
EBT excluding unusual items
145.00M
117.64M
154.00M
242.00M
Income tax expense
115.00M
-10.00M
-66.00M
67.00M
Effective tax rate
83.33%
-6.58%
-44.00%
27.80%
Other operating expenses
-7.00M
24.00M
11.00M
-4.00M
Net income
23.00M
161.00M
214.00M
172.00M
Net profit margin
3.89%
31.76%
37.35%
23.06%
Earnings per share
-
-
-
-
Interest and investment income
7.00M
6.00M
8.00M
3.00M
Interest expense
-52.00M
-43.00M
-37.00M
-48.00M
Net interest expenses
-45.00M
-37.00M
-29.00M
-45.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
264.00M
125.64M
227.00M
339.00M
Gain or loss from assets sale
-3.00M
-
2.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps